← Back to Search
Absence Of Germline Mutations In BAP1 In Sporadic Cases Of Malignant Mesothelioma.
Sophie Sneddon, J. S. Leon, I. Dick, G. Cadby, N. Olsen, F. Brims, R. Allcock, E. Moses, P. Melton, N. de Klerk, A. Musk, B. Robinson, J. Creaney
Published 2015 · Biology, Medicine
Download PDFAnalyze on Scholarcy
Malignant mesothelioma (MM) is a uniformly fatal tumour caused predominantly by exposure to asbestos. It is not known why some exposed individuals get mesothelioma and others do not. There is some epidemiological evidence of host susceptibility. BAP1 gene somatic mutations and allelic loss are common in mesothelioma and recently a BAP1 cancer syndrome was described in which affected individuals and families had an increased risk of cancer of multiple types, including MM. To determine if BAP1 mutations could underlie any of the sporadic mesothelioma cases in our cohort of patients, we performed targeted deep sequencing of the BAP1 exome on the IonTorrent Proton sequencer in 115 unrelated MM cases. No exonic germline BAP1 mutations of known functional significance were observed, further supporting the notion that sporadic germline BAP1 mutations are not relevant to the genetic susceptibility of MM.
This paper references
Familial aggregation of malignant mesothelioma in former workers and residents of Wittenoom, Western Australia
N. de Klerk (2013)
A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: malignant transformation is dose dependent.
C. Robinson (2006)
A conditional mouse model for malignant mesothelioma.
J. Jongsma (2008)
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
M. Carbone (2012)
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
K. Wang (2010)
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm
Prateek Kumar (2009)
Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration
H. Thorvaldsdóttir (2013)
Mutation and cancer: statistical study of retinoblastoma.
A. Knudson (1971)
The International HapMap Project
T. Tanaka (2003)
A method and server for predicting damaging missense mutations
I. Adzhubei (2010)
Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation.
C. Ribeiro (2013)
Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high‐risk area
M. Betti (2015)
Familial malignant mesothelioma: a population-based study in central Italy (1980-2012).
V. Ascoli (2014)
Prevalence of BRCA-1 associated protein 1 germline mutation in sporadic malignant pleural mesothelioma cases.
Andreas Rusch (2015)
Germline mutations in BAP1 predispose to melanocytic tumors
T. Wiesner (2011)
A genome-wide association study for malignant mesothelioma risk.
G. Cadby (2013)
Germline BAP1 mutations predispose to malignant mesothelioma
J. Testa (2011)
Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma.
Jinfei Xu (2014)
Germline BAP1 mutations predispose to renal cell carcinomas.
Tatiana Popova (2013)
The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.
A. McKenna (2010)
Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the assessment of pleural abnormalities in cancer patients: a systematic review and a meta-analysis.
G. Treglia (2014)
This paper is referenced by
Inherited Genetic Mutations and Polymorphisms in Malignant Mesothelioma: A Comprehensive Review
V. Panou (2020)
Malignant Mesothelioma: Time to Translate?
A. Napolitano (2016)
Targeting BAP1: a new paradigm for mesothelioma.
L. Schunselaar (2017)
Mesothelioma families without inheritance of a BAP1 predisposing mutation.
V. Ascoli (2016)
BAP1 mutations in mesothelioma: advances and controversies
Sophie Sneddon (2016)
Mesothelioma from asbestos exposures: Epidemiologic patterns and impact in the United States
R. Lemen (2016)
Genetics and Epigenetics of Mesothelioma
A. Aspesi (2019)
CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.
M. Betti (2016)
The genetic susceptibility in the development of malignant pleural mesothelioma.
O. Melaiu (2018)
Malignant Mesothelioma and Its Non-Asbestos Causes.
R. Attanoos (2018)
Malignant cells from pleural fluids in malignant mesothelioma patients reveal novel mutations.
Sophie Sneddon (2018)
Molecular characterisation of murine and human malignant mesothelioma and the identification of neoantigens as potential targets for therapy using next generation sequencing
Sophie Sneddon (2017)
Iron addiction with ferroptosis‐resistance in asbestos‐induced mesothelial carcinogenesis: Toward the era of mesothelioma prevention
S. Toyokuni (2019)
Comparative genetics of diffuse malignant mesothelioma tumors of the peritoneumand pleura, with focus on BAP1 expression
M. Brevet (2016)
Genetic predisposition for malignant mesothelioma: A concise review.
M. Betti (2019)
Genomic Landscape of Malignant Mesotheliomas
S. Kato (2016)
Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes
M. Betti (2018)
Malignant Mesothelioma: Mechanism of Carcinogenesis
A. Kane (2014)
Genomic Landscape of Malignant Mesotheliomas.
S. Kato (2016)
Epidemiology of Mesothelioma
S. Moolgavkar (2017)
1 CDKN 2 A and BAP 1 germline mutations predispose to melanoma and mesothelioma 1
M. Betti ()
Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines
Cindy Chau (2019)
What's new in mesothelioma.
V. Ascoli (2018)
III Italian Consensus Conference on Malignant Mesothelioma of the Pleura. Epidemiology, Public Health and Occupational Medicine related issues.
C. Magnani (2015)